Cargando…
Evaluation of dithiothreitol-oxidizing capacity (DOC) as a serum biomarker for chronic hepatitis B in patients exhibiting normal alanine aminotransferase levels: a pilot study towards better monitoring of disease
BACKGROUND: Alanine aminotransferase (ALT) is the most commonly used serum biomarker for chronic liver diseases (CLDs) but may not accurately reflect hepatic disorders and easily underestimates hepatic fibrosis. The previously revised upper limit of normal (ULN) of ALT (19 U/L for women and 30 U/L f...
Autores principales: | Yang, Lumin, Zhang, Yafei, Zhang, Ke, Liu, Zhongping, He, Tengfei, Zheng, Xiaowei, Li, Lei, Arnér, Elias S J, Zhang, Zhenhua, Zhang, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569636/ https://www.ncbi.nlm.nih.gov/pubmed/34765954 http://dx.doi.org/10.1016/j.eclinm.2021.101180 |
Ejemplares similares
-
Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021) -
Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021) -
Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study
por: Zhang, Junli, et al.
Publicado: (2018) -
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015) -
Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report
Publicado: (2022)